164 related articles for article (PubMed ID: 14643021)
1. Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis.
Wei M; Morimura K; Wanibuchi H; Shen J; Doi K; Mitsuhashi M; Moku M; Salim EI; Fukushima S
Cancer Lett; 2003 Dec; 202(1):11-6. PubMed ID: 14643021
[TBL] [Abstract][Full Text] [Related]
2. JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats.
Wei M; Morimura K; Wanibuchi H; Shen J; Salim EI; Moku M; Hakoi K; Fukushima S
Int J Cancer; 2005 Jan; 113(3):354-8. PubMed ID: 15455344
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Rao CV; Seibert K
Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.
Kawamori T; Uchiya N; Kitamura T; Ohuchida S; Yamamoto H; Maruyama T; Sugimura T; Wakabayashi K
Anticancer Res; 2001; 21(6A):3865-9. PubMed ID: 11911260
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats.
Yoshimi N; Kawabata K; Hara A; Matsunaga K; Yamada Y; Mori H
Jpn J Cancer Res; 1997 Nov; 88(11):1044-51. PubMed ID: 9439679
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of development of N,N'-dimethylhydrazine-induced rat colonic aberrant crypt foci by pre, post and simultaneous treatments with 24R,25-dihydroxyvitamin D3.
Salim EI; Wanibuchi H; Taniyama T; Yano Y; Morimura K; Yamamoto S; Otani S; Nishizawa Y; Morii H; Fukushima S
Jpn J Cancer Res; 1997 Nov; 88(11):1052-62. PubMed ID: 9439680
[TBL] [Abstract][Full Text] [Related]
8. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.
Takahashi M; Fukutake M; Yokota S; Ishida K; Wakabayashi K; Sugimura T
J Cancer Res Clin Oncol; 1996; 122(4):219-22. PubMed ID: 8601574
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
Rao CV; Kawamori T; Hamid R; Reddy BS
Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
[TBL] [Abstract][Full Text] [Related]
10. Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model.
Sharma P; Kaur J; Sanyal SN
Nutr Hosp; 2010; 25(1):39-48. PubMed ID: 20204254
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of azoxymethane-induced colon carcinogenesis in rats due to JTE-522, a selective cyclooxygenase-2 inhibitor.
Shen J; Wanibuchi H; Salim EI; Wei M; Yamachika T; Fukushima S
Asian Pac J Cancer Prev; 2004; 5(3):253-8. PubMed ID: 15373703
[TBL] [Abstract][Full Text] [Related]
12. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
Yamamoto H; Kondo M; Nakamori S; Nagano H; Wakasa K; Sugita Y; Chang-De J; Kobayashi S; Damdinsuren B; Dono K; Umeshita K; Sekimoto M; Sakon M; Matsuura N; Monden M
Gastroenterology; 2003 Aug; 125(2):556-71. PubMed ID: 12891558
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
14. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M
Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187
[TBL] [Abstract][Full Text] [Related]
15. Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci.
Ziliotto L; Barbisan LF; Rodrigues MA
Hum Exp Toxicol; 2008 Jun; 27(6):505-11. PubMed ID: 18784204
[TBL] [Abstract][Full Text] [Related]
16. Unexpected antagonistic action of 3,2'-dimethyl-4-aminobiphenyl on aberrant crypt induction by 1,2-dimethylhydrazine or azoxymethane in rat colon.
Steffensen IL; Paulsen JE; Alexander J
Carcinogenesis; 1995 Dec; 16(12):2981-8. PubMed ID: 8603473
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
18. Arabinoxylan-oligosaccharides (AXOS) reduce preneoplastic lesions in the colon of rats treated with 1,2-dimethylhydrazine (DMH).
Femia AP; Salvadori M; Broekaert WF; François IE; Delcour JA; Courtin CM; Caderni G
Eur J Nutr; 2010 Mar; 49(2):127-32. PubMed ID: 19711111
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
[TBL] [Abstract][Full Text] [Related]
20. Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2'-dimethyl-4-aminobiphenyl.
Feng Y; Fretland AJ; Rustan TD; Jiang W; Becker WK; Hein DW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):56-62. PubMed ID: 9356307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
